Analyst Price Targets — MEDP
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 13, 2026 10:19 am | David Windley | Jefferies | $560.00 | $416.04 | TheFly | Medpace upgraded to Buy from Hold at Jefferies |
| February 11, 2026 1:44 pm | — | Truist Financial | $539.00 | $431.17 | TheFly | Medpace price target lowered to $539 from $555 at Truist |
| February 11, 2026 12:55 pm | — | Mizuho Securities | $582.00 | $446.05 | TheFly | Medpace price target lowered to $582 from $660 at Mizuho |
| February 11, 2026 12:07 pm | — | BMO Capital | $460.00 | $446.05 | TheFly | Medpace price target lowered to $460 from $600 at BMO Capital |
| February 10, 2026 6:49 pm | — | Robert W. Baird | $564.00 | $455.64 | TheFly | Medpace upgraded to Outperform from Neutral at Baird |
| January 9, 2026 12:09 pm | — | Mizuho Securities | $660.00 | $600.02 | TheFly | Medpace price target raised to $660 from $655 at Mizuho |
| December 15, 2025 10:55 am | Luke Sergott | Barclays | $525.00 | $557.78 | TheFly | Medpace price target raised to $525 from $485 at Barclays |
| October 27, 2025 1:50 pm | Jailendra Singh | Truist Financial | $555.00 | $605.20 | TheFly | Medpace price target raised to $555 from $436 at Truist |
| October 24, 2025 12:08 pm | — | Robert W. Baird | $613.00 | $596.61 | TheFly | Medpace price target raised to $613 from $491 at Baird |
| October 24, 2025 11:02 am | — | Mizuho Securities | $655.00 | $597.45 | TheFly | Medpace price target raised to $655 from $575 at Mizuho |
Latest News for MEDP
Medpace (MEDP) reached $447.09 at the closing of the latest trading day, reflecting a +2.06% change compared to its last close.
Citizens Business Bank bought a new position in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,790 shares of the company's stock, valued at approximately $920,000. A number of other hedge funds and other institutional
New York, New York--(Newsfile Corp. - February 23, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Medpace Holdings, Inc. ("Medpace Holdings, Inc.") (NASDAQ: MEDP) concerning potential violations of the federal securities laws. On February 10, 2026, Medpace shares fell approximately 10% by mid-day and closed down 15.9%, according to data from Quiver Quantitative and GuruFocus.
(NASDAQ: MEDP) NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Medpace Holdings, Inc. (NASDAQ: MEDP) concerning potential securities law claims on behalf of shareholders. The investigation centers on whether the company and its senior officers made statements about the health of its clinical-trial booking pipeline that were inconsistent with internal data showing elevated cancellation…
Pre-Market Stock Futures: Futures are trading higher after a sluggish start to the holiday-shortened trading week. While stocks started as if it were going to be another risk-off day, they turned positive by late morning, and all the indices ended the day modestly higher. With a trove of economic data on the way, and fourth-quarter... Here Are Wednesday's Top Wall Street Analyst Research Calls: Cadence Design, Crox,…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MEDP.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.